---
id: 135
title: Toxoplasma gondii and Toxoplasmosis
category: organisms
subcategory: parasites
tags: [toxoplasma, toxoplasmosis, pyrimethamine, sulfadiazine, ring-enhancing, HIV]
difficulty: medium
---

## Question

How is toxoplasmosis diagnosed and treated? Use the **"Ring-Enhancing Lesions (HIV) = Empiric Toxo Treatment, Pyrimethamine + Sulfadiazine"** framework.

## Answer

### ***Toxoplasma gondii* Overview:**

**Transmission:**
- **Cats** (definitive host) → oocysts in feces
- **Undercooked meat** (lamb, pork) → tissue cysts
- **Congenital** → transplacental (primary infection in pregnancy)
- **Transplant** → donor organ (D+/R-)

**Clinical Syndromes:**
- **Immunocompetent:** Usually asymptomatic OR mild mononucleosis-like illness
- **HIV/AIDS (CD4 <100):** **Toxoplasma encephalitis** (most common CNS mass lesion)
- **Congenital:** Chorioretinitis, hydrocephalus, intracranial calcifications
- **Transplant:** Reactivation (D+/R- highest risk)

### **Toxoplasma Encephalitis (HIV/AIDS):**

**Presentation:**
- **Headache**, **confusion**, **focal neurologic deficits**, **seizures**
- **Fever** (50%)

**Imaging:**
- **MRI (preferred):** **Multiple ring-enhancing lesions** (basal ganglia common), **mass effect**, **edema**
- **CT:** Less sensitive, but shows ring-enhancing lesions

**Diagnosis:**
- **Presumptive:** CD4 <100 + ring-enhancing lesions + **positive Toxoplasma IgG**
- **Definitive:** Brain biopsy (rarely needed) - tachyzoites, cysts, or PCR

**Empiric Treatment:**
- **Start empiric anti-Toxoplasma therapy** if presumptive diagnosis
- **Clinical/radiographic response** by 10-14 days → **confirms diagnosis**
- **If no response by 14 days:** Consider brain biopsy (rule out lymphoma, fungal, TB)

### **Treatment:**

**Acute Toxoplasma Encephalitis (Induction, ≥6 Weeks):**
- **Pyrimethamine** 200mg PO × 1 (loading) → 50-75mg PO daily
- **+**
- **Sulfadiazine** 1000-1500mg PO QID (weight-based)
- **+**
- **Leucovorin (folinic acid)** 10-25mg PO daily (prevent bone marrow suppression from pyrimethamine)

**Alternative (if sulfa allergy):**
- **Pyrimethamine + leucovorin** (as above)
- **+**
- **Clindamycin** 600mg PO/IV q6h

**Maintenance (Secondary Prophylaxis, Lifelong Until Immune Reconstitution):**
- **Pyrimethamine** 25-50mg PO daily + **sulfadiazine** 2000-4000mg daily (divided BID-QID) + **leucovorin** 10-25mg daily
- **Continue** until CD4 >200 × 6 months on ART

**Primary Prophylaxis (CD4 <100 + Toxoplasma IgG+):**
- **TMP-SMX DS daily** (covers both PCP and Toxoplasma)
- **Alternative:** Dapsone 50mg daily + pyrimethamine 50mg weekly + leucovorin 25mg weekly

### **Congenital Toxoplasmosis:**

**Classic Triad (Rare, Severe):**
- **Chorioretinitis**
- **Hydrocephalus**
- **Intracranial calcifications**

**Screening:**
- **Maternal:** Toxoplasma IgG/IgM (if primary infection suspected)
- **Fetal:** Amniocentesis (PCR for *T. gondii* DNA)

**Treatment (Congenital):**
- **Pyrimethamine + sulfadiazine + leucovorin** × 12 months
- **Add prednisone** if active chorioretinitis or CSF protein >1 g/dL

**Prevention:**
- **Avoid undercooked meat**, **wash vegetables**, **avoid cat litter** (pregnant women)

## Key Points

### **Differential Diagnosis (Ring-Enhancing Lesions, HIV):**

| Diagnosis | Features | Distinguishing Features |
|-----------|----------|------------------------|
| **Toxoplasma** | Multiple lesions, basal ganglia, **Toxo IgG+** | **Most common**, responds to empiric therapy by 10-14 days |
| **Primary CNS lymphoma** | Single lesion (often periventricular), **EBV+** CSF PCR, **Toxo IgG-** | **PET-CT:** Avid FDG uptake (vs toxo = low uptake) |
| **Tuberculoma** | Ring-enhancing, systemic TB symptoms | **CSF AFB**, tuberculosis elsewhere |
| **Cryptococcoma** | Mass lesion, **CSF CrAg+** | Serum/CSF cryptococcal antigen |
| ***Nocardia*** | Brain abscess, pulmonary nodules | Gram stain (branching, weakly acid-fast) |

### **Pyrimethamine + Sulfadiazine:**
- **Mechanism:** Both inhibit folate synthesis (*Toxoplasma* dependent on de novo folate)
- **Synergy:** Combination highly effective
- **Leucovorin (folinic acid) mandatory:** Prevents bone marrow suppression (pyrimethamine is antifolate)
- **Monitor:** CBC weekly × 4 weeks → biweekly (watch for cytopenias)

### **When to Stop Prophylaxis:**
- **Primary prophylaxis:** CD4 >200 × 3 months on ART
- **Secondary prophylaxis:** CD4 >200 × 6 months on ART + no symptoms + completed ≥6 weeks treatment

### **Ocular Toxoplasmosis:**
- **Chorioretinitis** (most common cause worldwide)
- **Presentation:** Blurred vision, floaters, pain, photophobia
- **Fundoscopy:** "Headlight in the fog" (focal retinitis with overlying vitreous haze)
- **Treatment:** Pyrimethamine + sulfadiazine + leucovorin + **prednisone** (if vision-threatening or macula involved)

### **Clinical Pearls:**
- **CD4 <100 + ring-enhancing lesions + Toxo IgG+** = empiric toxoplasmosis treatment
- **Pyrimethamine + sulfadiazine + leucovorin** × ≥6 weeks (induction)
- **Clinical response by 10-14 days** confirms diagnosis (if no response → biopsy)
- **TMP-SMX DS daily** prevents both PCP + Toxoplasma (dual prophylaxis)
- **Primary CNS lymphoma:** Single lesion, EBV+ CSF PCR, PET-avid
- **Leucovorin mandatory** (prevent bone marrow suppression)

## Sources

- [CDC/NIH/IDSA: OI Guidelines in HIV 2024]
- [IDSA: Toxoplasmosis Guidelines 2023]

## Media

N/A
